30531687|t|Intranasal Calcitonin Gene-Related Peptide Protects Against Focal Cerebral Ischemic Injury in Rats Through the Wnt/beta-Catenin Pathway.
30531687|a|BACKGROUND Intranasal calcitonin gene-related peptide (CGRP) delivery offers a noninvasive method of bypassing the blood-brain barrier for the delivery of CGRP to the brain. Here, we first reported the therapeutic benefits of intranasal CGRP delivery in rats following middle cerebral artery occlusion (MCAO). MATERIAL AND METHODS Real-time quantitative polymerase chain reaction (RT-qPCR) assay, enzyme-linked immunosorbent assay (ELISA), rat MCAO model, TTC (2, 3, 5-triphenyltetrazolium chloride) staining, hematoxylin and eosin (H & E) staining, Morris water maze test, TUNEL assay, immunofluorescence, and western blot assay were used to investigate the role of CGRP in rats. Cell Counting Kit-8 assay, colony formation assay, cell cycle assay, apoptosis assay, western blot assay, and TOP/FOP assay were used to investigate the role of CGRP in normal human astrocytes (NHA) cells. RESULTS The CGRP-MCAO-NDDS (nasal drug delivery system) group showed a significant reduction in the infarct volume and improvement in neurologic deficit tests of motor, sensory, reflex and vestibulo-motor functions compared to those rats in the CGRP-MCAO-IV group. CGRP markedly inhibited apoptosis and increased the expression of vascular endothelial growth factor (VEGF) and bFGF and decreased the expression of GAP43 in the cortex of MCAO rats. CGRP promoted cell proliferation and cell cycle process and inhibited cell apoptosis through the Wnt/beta-catenin pathway in NHA cells. CONCLUSIONS This noninvasive, simple, and cost-effective method is a potential treatment strategy for focal cerebral ischemic injury.
30531687	11	42	Calcitonin Gene-Related Peptide	Gene	24241
30531687	66	90	Cerebral Ischemic Injury	Disease	MESH:D017202
30531687	94	98	Rats	Species	10116
30531687	111	114	Wnt	Gene	114487
30531687	115	127	beta-Catenin	Gene	84353
30531687	159	190	calcitonin gene-related peptide	Gene	24241
30531687	192	196	CGRP	Gene	24241
30531687	292	296	CGRP	Gene	24241
30531687	374	378	CGRP	Gene	24241
30531687	391	395	rats	Species	10116
30531687	406	438	middle cerebral artery occlusion	Disease	MESH:D020244
30531687	440	444	MCAO	Disease	MESH:D020244
30531687	577	580	rat	Species	10116
30531687	581	585	MCAO	Disease	MESH:D020244
30531687	593	596	TTC	Chemical	-
30531687	598	635	2, 3, 5-triphenyltetrazolium chloride	Chemical	MESH:C009591
30531687	647	668	hematoxylin and eosin	Chemical	-
30531687	670	675	H & E	Chemical	MESH:D006371
30531687	804	808	CGRP	Gene	24241
30531687	812	816	rats	Species	10116
30531687	979	983	CGRP	Gene	796
30531687	994	999	human	Species	9606
30531687	1012	1015	NHA	CellLine	CVCL:B5WG
30531687	1036	1040	CGRP	Gene	24241
30531687	1041	1045	MCAO	Disease	MESH:D020244
30531687	1124	1131	infarct	Disease	MESH:D007238
30531687	1158	1176	neurologic deficit	Disease	MESH:D009461
30531687	1257	1261	rats	Species	10116
30531687	1269	1273	CGRP	Gene	24241
30531687	1274	1278	MCAO	Disease	MESH:D020244
30531687	1289	1293	CGRP	Gene	24241
30531687	1355	1389	vascular endothelial growth factor	Gene	83785
30531687	1391	1395	VEGF	Gene	83785
30531687	1401	1405	bFGF	Gene	54250
30531687	1438	1443	GAP43	Gene	29423
30531687	1461	1465	MCAO	Disease	MESH:D020244
30531687	1466	1470	rats	Species	10116
30531687	1472	1476	CGRP	Gene	24241
30531687	1569	1572	Wnt	Gene	114487
30531687	1573	1585	beta-catenin	Gene	84353
30531687	1597	1600	NHA	CellLine	CVCL:B5WG
30531687	1716	1740	cerebral ischemic injury	Disease	MESH:D017202
30531687	Association	MESH:D017202	84353
30531687	Negative_Correlation	MESH:D017202	24241
30531687	Positive_Correlation	24241	54250
30531687	Association	MESH:D020244	24241
30531687	Negative_Correlation	24241	29423
30531687	Negative_Correlation	MESH:D009461	24241
30531687	Association	24241	84353
30531687	Association	114487	24241
30531687	Positive_Correlation	24241	83785
30531687	Negative_Correlation	MESH:D007238	24241
30531687	Association	114487	84353

